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http://www.biomedcentral.com/1472-6882/14/34RESEARCH ARTICLE Open AccessSoyo-san reduces depressive-like behavior and
proinflammatory cytokines in ovariectomized
female rats
Hyun-Jung Park1†, Hyun-Soo Shim1,2†, Sun Yong Chung3, Tae Hee Lee4 and Insop Shim1*Abstract
Background: Soyo-san is a traditional oriental medicinal formula, a mixture of 9 crude drugs, and it has been
clinically used for treating mild depressive disorders. The role of pro- and anti-inflammatory cytokines in psychiatric
disorders has been the focus of great research attention in recent years. In the present study, we detected the
antidepressant effect of soyo-san in the ovariectomized and repeated stressed female rats.
Methods: This study was designed to evaluate the antidepressant-like effect of soyo-san on the forced swimming
test (FST). The rats were randomly divided into the following groups: the nonoperated and nonstressed group (non-op),
the nonoperated and stressed group (non-op + ST), the ovariectomized and stress group (OVX) and sham operated and
stressed group (sham), the ovariectomized and stressed group (OVX + ST), the ovariectomized, stressed and soyo-san
100 mg/kg treated group (SOY100) and the ovariectomized, stressed and soyo-san 400 mg/kg treated group (SOY400).
The rats were exposed to immobilization stress (IMO) for 14day (2 h/14day), and soyo-san (100 mg/kg and 400 mg/kg)
was administrated during the same time. In the same animals, the levels of corticosterone and interleukin-1-beta (IL-1β)
were examined in the serum. Also, the change of IL-1β expression in brain regions was examined after behavior test.
Results: In the FST, the lower dose (100 mg/kg) of extract was effective in reducing immobility, along with an increase
in swimming time. The serum levels of corticosterone and IL-1β in the SOY groups were significantly lower than those
in the control group. In the brain, the expression of IL-1β positive neurons in the control group were significantly
increased in the paraventricular nucleus (PVN) and hippocampus compared to the non-op. However, soyo-san groups
significantly reduced the IL-1β-ir neurons in the PVN and hippocampal regions compared to the control.
Conclusion: The present results demonstrated that soyo-san effectively reduced behavioral and patho-physiological
depression-like responses. Trial registration: Our results suggest that soyo-san may be useful for immune regulator in
repeated stress-induced ovariectomized female rats.Background
Postmenopausal women often suffer from symptoms called
postmenopausal syndrome. These symptoms consist of hot
flush and mental symptoms such as depression, irritation
and insomnia [1,2]. Menopause is associated with a rapid
decline in circulating sexual hormones and results in meno-
pausal syndrome, including hot flushes, osteoporosis and
affective disorders, for example, anxiety and depression.
Those symptoms are known to be related to the decrease* Correspondence: ishim@khu.ac.kr
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reproduction in any medium, provided the orof the serum 17β-estradiol (E2) level [2,3]. The decrease of
E2 has an influence on regulating the production of cortico-
sterone and changing the behavioral response under the
stress condition.
Repeated immobilization stress or unpredictable foot-
shock elicit sickness behaviors, which may reflect part of a
constellation of adaptive changes elicited by macrophage
derived cytokines, such interleukin-1β and interferon-γ
[4,5]. These cytokines may directly or indirectly affect CNS
processes [6] and thus may have implications for psycho-
pathology, including depressive illness if the increased level
of pro-inflammatory cytokines is involved in the etiology of
depression, it may be expected that antidepressants should
have a restoring immunoregulatory effect. Pharmacological. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Table 1 Composition of soyo-san
Medicinal plant Amount (g)
Paeoliae Radix Alba 4.0
Atractylodis Macrocephalae Phizoma 4.0






Zingiberi Rhizoma Recens 6.0
Total 34.0
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as desipramine [7,8] have indicated the involvement of
noradrenergic system underlying the effects of antidepres-
sants on immune activity.
We already reported that the antidepressant effects of
soyo-san on immobilization stress in ovariectomized fe-
male rats. The treatment with soyo-san caused significant
reversals of the stress-induced deficits in learning and
memory on a spatial memory task, and it also produced
an anxiolytic-like effect on the EPM, and increased the
ChAT and AchE reactivities. The serum level of cortico-
sterone in the soyosan treated group was significantly
lower than that in the control group. In this study, we
aimed to investigate whether administration of soyo-san
could modulate depressive–like behavior and production
of pro-inflammatory cytokines. To achieve this goal, soyo-
san’s antidepressant effect was tested via a forced swim-
ming test (FST); moreover, the influence of soyo-san in
producing of IL-1β was further assessed in the serum and
brain regions using the ELISA and immunohistochemistry.
Methods
Subjects and stress procedure
Sprague Dawley female rats at the age of 3 months (Orient,
Inc. Korea) were used for the study. The rats were housed
under a controlled temperature (22-24°C) with a 12 h light/
dark cycle. The lights were on from 8:00 to 20:00. Food and
water were made available ad libitum. They were allowed at
least 1 week to adapt to their environment before the experi-
ments. The animal experiments were carried out in accor-
dance with the Prevention of Cruelty to Animals Act 1986
and NIH guidance for the care and use of laboratory animals
for experimental procedures, and all experiments in this study
were approved by the Institutional Animal Care and Use
Committee of Kyung Hee University (KHUAP(SE)-13-041).
The rats were randomly divided into the following
groups: the nonoperated and nonstressed group (non-
op), the nonoperated and stressed group (non-op + ST),
the ovariectomized and stress group (OVX) and sham op-
erated and stressed group (sham), the ovariectomized and
stressed group (OVX + ST), the ovariectomized, stressed
and soyo-san 100 mg/kg treated group (SOY100) and
the ovariectomized, stressed and soyo-san 400 mg/kg
treated group (SOY400). Using aseptic conditions, bila-
teral ovariectomy was performed under general anesthesia
with pentobarbital sodium (50 mg/kg, i.p.). After post-
operative recovery for 1 week, the ovariectomized rats
were stressed daily. Stress was produced by forcing the
animals into an immobilizer device (a disposable rodent
restraint cone) for 2 hours (10:00–12:00 a.m.) for 2 weeks.
The soyo-san group was orally administrated once
daily for 2 weeks, and other groups were given sterile
saline. Drug treatments began 30 min before the
immobilization stress.Preparation of herbal extracts
Soyo-san was purchased from an oriental drug store
(Jungdo Inc. Seoul, Korea). The boucher specimens are de-
posited at the herbarium located in the College of Oriental
Medicine, Kyung Hee University. The dried soyo-san sam-
ples (720.58 g, Table 1) were immersed in a 10-fold volume
of distilled water, boiled at 80°C for 1 h, and then the water
extract was collected. The process was repeated once, and
the extracts were combined and concentrated with a ro-
tary evaporator and vacuum-dried to yield 6.6% (w/w) of
the extract.Forced swimming test
From the 14th day after the first immobilization, rats
were placed in an FST, The time interval was 5 min.
The FST was originally described by Porsolt et al. [9]
and now is the most widely used pharmacological model
for assessing antidepressant activity [10]. The development
of immobility when the rodents are placed in an inescap-
able cylinder of water reflects the cessation of persistent
escape-directed behavior [11]. The apparatus consisted of
a transparent Plexiglas cylinder (50 cm high × 20 cm wide)
filled to a 30 cm depth with water at room temperature.
In the pre-test, rats were placed in the cylinder for 15 min,
24 h prior to the 5-min swimming test. Soyo-san extract
(100, 400 mg/kg) or saline was administrated p.o. three
times: immediately after the initial 15 min pre-test, 5 and
1 h prior to the swimming test. During the 5-min swim-
ming test, the following behavioral responses were re-
corded by a trained observer: Climbing behavior, which is
defined as upward-directed movements of the forepaws
along the side of the swim chamber. Swimming behavior,
defined as movement throughout the swim chamber,
which included crossing into another quadrant. Immobil-
ity was considered when the rat made no further attempts
to escape except the movement necessary to keep its head
above the water. Increases in active responses, such as
climbing or swimming, and reduction in immobility, are
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antidepressant-like action [10].
Corticosterone and cytokine measurements
After the behavior test, blood sample was taken in heart
and then plasma separated from the blood was used to es-
timate the cytokine levels. Enzyme-linked immunosorbent
assay (ELISA) was performed using Quantikine ELISA de-
velopment system according to the manufacturer’s instruc-
tions (R & D Systems, Minneapolis, MN, USA). Briefly,
polystyrene microtiter plates (NUNC, U16 Maxisorp type,
Roskilde, Denmark) were coated with monoclonal anti-
body (anti-rat IL-1β and corticosterone) obtained from rat
(R & D Systems) and incubated at 4°C overnight. The fol-
lowing day, the plates were blocked and then incubated
for 2 h with plasma. This was followed by the addition of
corresponding biotinylated detection antibody obtained
from rat (R & D Systems) and incubated for 2 h. Streptavi-
din horseradish peroxidase (R & D Systems) and, then, tet-
ramethylbenzidine substrate (Bangalore Genei, Bangalore,
India) treatment followed this incubation. The reaction
was stopped using 2 N sulfuric acid, and optical density
reading was taken at 450 nm (ELISA reader: Organon
Teknika Microwell system, Reader 230 s, Eppelheim,
Germany). All the experiments were conducted in du-
plicate. A standard curve was obtained based on the stan-
dards provided by the manufacturer. The results were
expressed as concentration of cytokines (in pg/ml) read
from the standard curve.
IL-1β immunohistochemistry
After the behavioral testing was completed, all of the ani-
mals were deeply anesthetized with sodium pentobarbital
(80 mg/kg, i.p.) also, blood sample was taken in heart and
then they were perfused through the ascending aorta with
normal saline (0.9%), followed by 800 ml of 4% para-
formaldehyde in 0.1 M phosphate buffer saline (PBS). The
brains were removed, postfixed overnight and cryopro-
tected in 20% sucrose in 0.1 M PBS at 4°C. The brains
were cut by cryostat sectioning into 30 μm coronal sec-
tions at the level of the hippocampus, and these slices
were processed histochemically as free-floating sections.
The brain sections were washed in PBS containing
0.3% Triton X-100. The primary goat polyclonal anti-
bodies against the following specific antigen were used:
Intetleukin-1-beta (IL-1β, concentration 1:100; R&D Sys-
tems, Minneapolis, USA). The primary antibodies were di-
luted with blocking solution (10% fetal bovine serum in
PBS, pH = 7.4) and the tissues were incubated for 72 h
at 4°C with constant agitation. Following rinsing in PBS,
the sections were incubated for 2 h at room tempera-
ture in biotinylated goat anti-serum (Vector Laboratories,
Burlingame, CA) that was diluted 100:1 in PBST contain-
ing 2% normal rabbit serum. The sections were placedin Vectastain Elite ABC reagent (Vector Laboratories,
Burlingame, CA) for 2 h at room temperature. Following
a further rinsing in PBS, the tissue was developed using
diaminobenzidine chromogen with nickel intensification.
The sections were mounted on gelatine-coated slides, air-
dried and coverslipped for microscopic observation. For
measuring the cells, a microrectangular grid (200 × 200um)
was placed according to the atlas of Paxinos and Watson
under the light microscope (×100 magnification) [12].
Data analysis
Statistical comparisons were done for the behavioral,
histochemical and immunological studies using the one-
way ANOVA, respectively, and Tukey post hoc was done.
All of the results were presented as means ± S.E.M., and
we used SPSS 15.0 for Windows for analysis of the sta-
tistics. The significance level was set at p < 0.05.
Results
Forced swimming test
The effect of the soyo-san on active behaviors in the FST
of rats are shown in Figure 1. ANOVA revealed effects of
the treatment of soyo-san on immobility, F3,30 = 5.214, P <
0.05; swimming behavior, F3,30 = 0.328; and climbing be-
havior, F3,30 = 0.150. Post hoc analysis demonstrated that
soyo-san treatment groups significantly shortened the im-
mobility time in comparison to control values (P < 0.05).
This effect was accompanied by increases in swimming
behavior, after 100 and 400 mg/kg. These results indicated
that higher doses (400 mg/kg) were more effective than
soyo-san 100 mg in reducing immobility time.
ELISA
1) Corticosterone (CORT)
Figure 2A shows that the serum levels of CORT
were significantly different in comparisons among
the groups (F3,30 =4.093, P < 0.05). The serum
levels of CORT were 195.6 ± 15.4, 226.3 ± 42.4,
179.1 ± 40.3 and 99.1 ± 19.6 (ng/ml) in the non-op,
OVX+ST, SOY100 and SOY400 groups, respect-
ively. The LSD test results indicated a significantly
increased the serum levels of CORT in the non-op
group compared to the OVX+ST group (P < 0.05).
After treatment of soyo-san, the serum levels of
CORT were significantly decreased in the SOY100
group (P <0.05) and SOY400 group (P < 0.01)
compared to the OVX+ST group.
2) IL-1β
Figure 2B. shows that the serum levels of IL-1β
were significantly different in comparisons among
the groups (F3,30 =4.1, P < 0.05). The serum levels
of IL-1β were 15.6 ± 4.0, 30.6 ± 3.3, 19.3 ± 3.0 and
18.7 ± 2.4 (pg/ml) in the non-op, OVX+ST,
Figure 1 The effects of soyo-san extract on CORT (A), IL-1β (B) levels in the serum. The results of ELISA were analyzed by performing
separate one-way ANOVA among the groups. Each value represents the mean ± S.E.M. *P < 0.05, **P < 0.01 compared to OVX +ST. #P < 0.05,
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LSD test results indicated a significantly increased
the serum levels of IL-1β in the non-op group
compared to the stressed group (P < 0.01). After
treatment of soyo-san, the serum levels of IL-1β
were significantly decreased to 33.0% of the stress
in the soyo-san groups (P < 0.05).IL-1β Immunohitochemistry
The results of determining the IL-1β immunoreative cells
per section from different hippocampal formations and
paraventricular nucleus are shown in Figures 3 and 4. The
number of IL-1β neurons in the CA1 area was 10.1 ± 0.6
in the non-op group, 3.9 ± 0.6 in the OVX group, 3.0 ± 0.3
in the SOY100 group and 6.0 ± 0.4 in the SOY400 group
[F3,20 = 11.7, P < 0.001; 3A-I]. IL-1β immunoreactive cells inure 2 The climbing and swimming time (A) and the immobility tim
f the duration of climbing, swimming and immobility during the 5-min
-way ANOVA of mean counts among the groups. Each value represent
pared to non-op.the CA3 area were 18.4 ± 0.6 in the non-op group, 13.7 ±
0.8 in the OVX group, 12.9 ± 0.3 in the SOY100 group and
15.7 ± 0.5 in the SOY400 group [F3,20 = 6.0, P < 0.01].
Also, the number of IL-1β positive neurons was signi-
ficantly increased to 121.7% of the OVX in the non-op
group (P < 0.01). The number of IL-1β neurons in the PVN
area was 7.2 ± 1.5 in the non-op group, 27.3 ± 1.3 in the
OVX group, 13.5 ± 1.8 in the SOY100 group and 11.8 ± 1.5
in the SOY400 group [F3,20 = 32.4, P < 0.001; 4A-E].
Discussion
The present study demonstrated that the administration
of soyo-san reduced the depressive behavior and pro-
inflammatory cytokine expression. These results suggest
that repeated immobilization stress in the ovariectomized
female rats is an immune challenge capable of inducinge (B) of rats on the forced swimming. Data represent means ± S.E.
test session. The results of FST were analyzed by performing separate
s the mean ± S.E.M. *P < 0.05 compared to OVX+ST. #P < 0.05
Figure 3 The effect of soyo-san extract on quantities of IL-1β immunostained nuclei expression in the hippocampal regions of the
experimental groups after forced swimming test. (A) The results of IL-1β-reactivity were analyzed by performing separate one-way ANOVA
of neurons among the groups. Each value represents the mean ± S.E.M. ***P < 0.001 compared to OVX+ST. ##P < 0.01 compared to non-op.
B-I: Representative photographs of IL-1β-immunostained brain sections. Scale bars, 200 um. non-op (B,F), OVX+ST (C,G), SOY 100 (D,H) and SOY
400 (E, I).
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corticoid responses to stress, and changing cytokine tran-
scription in the serum and the brain.
Depression is defined clinically as a pathological complex
of psychological, neuroendocrine and somatic symptoms
that cannot be reproduced in animals. To date, few models
are commonly used for screening antidepressant effects or
studying the mechanisms of action of these molecules. The
forced swimming test (FST) was discussed the main para-
meters that influence the sensitivity, specificity and reliability
of this model. Porsolt et al. (1977) [13] described “a new be-
havioural method for inducing a depressed state”. The idea
arose out of some learning experiments they were doing
with rats in a water maze. Most rats were finding the exit
within 10 min but they noticed that other rats ceased strug-
gling altogether and remained floating passively [9]. The
duration of immobility occurring in each minute was
scored. A wide variety of antidepressants, and compounds
with potential antidepressant activity, reduce the duration of
immobility in the forced swimming test [14-16]. The present
study confirms the previously reported antidepressant likeeffect of soyo-san. The reduction in immobility induced by
soyo-san was accompanied by increased swimming, while
that of soyo-san occurred with an increase in climbing be-
havior. The behavioral profiles observed in the present
study with soyo-san, in ovariectomized female rats, are
similar to those reported by other authors in male rats
[17-21]. Hence, the finding of Chen et al. [22] can also be
extended to repeated stress induced depression animal
model. In a Previous study, we also demonstrated that
Bupleuri radix, one of the most important constituents of
soyo saan, caused a significant anti-immobility effect on
the FST and reversed the CMS-induced reduction of su-
crose consumption [23]. In agreement with these findings,
the previous studies on major depressive disorder have
reported the elevation of IL-1β production during a de-
pressive state [24]. This study also showed the repeated
immobilization stress induced a broad spectrum of beha-
vioral changes that might be regarded as depression-like
symptoms, including reduction of preferences for sucrose
solution, inhibition of locomotor activities, and induction
of learned helplessness behavior.
Figure 4 The effect of soyo-san extract on quantities of IL-1β immunostained nuclei expression in the paraventricular regions of the
experimental groups after forced swimming test. (A) The results of IL-1β-reactivity were analyzed by performing separate one-way ANOVA
of neurons among the groups. Each value represents the mean ± S.E.M. ***P < 0.001 compared to non-op. #P < 0.05, ###P < 0.001 compared to
non-op. B-E Representative photographs of IL-1β-immunostained brain sections. Scale bars, 200um. non-op (B), OVX +ST, SOY 100 (D) and SOY
400 (E).
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associated with increased susceptibility to neurological dis-
orders [25], also the mechanisms were elucidated [25-27].
Previous studies revealed a substantial involvement of en-
dogenous estrogen in neuroinflammatory processes and
provide novel mechanisms for hormone action in the
brain [25-27]. Another study reported that the estrogen
replacement therapy (ERT) was related to exacerbate the
memory impairment induced by the chronic neuroinflam-
mation associated with Alzheimer’s disease [27]. In this
study, our aim is to investigate whether OVX animals are
more vulnerable to the inflammatory and behavioral effects
of chronic stress. Many studies proved that the repeated
stress accelerated expression of pro-inflammatory cyto-
kines in the brain [28-30]. Pro-inflammatory cytokines play
a key role in determining the nature and strength of im-
mune responses [31]. Previous studies have demonstratedthat the induction of pro-inflammatory cytokines activated
under stress condition. Stress (physical, psychological or
both of them) can increase an inflammatory responses.
The relationship between stressful events and the onset of
inflammatory related diseases (injury, ischemia, Alzheimer’s
disease) is well documented [32]. Stress response is very
similar to the inflammatory process generated in an or-
ganism when invaded by certain microorganisms or after
injury or tissue damage as oxidative stress. In rodents, un-
avoidable physical stresses are the most extensively used:
immobilization, exposure to extreme temperatures, fast-
ing, immersion or electric foot shock. Various studies have
provided inputs on the molecular signaling that links
stress-induced neuro-endocrine-immune interactions, sug-
gesting a bi-directional crosstalk which is based on the
secretion of cytokines, glucocorticoids, neurotransmitters
and neuropeptides [33]. The previous study proved that
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form of a greater hypothalamic-pituitary-adrenal (HPA)
axis response in female ICR mice is controlled by ovary-
derived factors in adults [34]. Ovariectomy expresses high
levels of adrenal steroid receptors and is susceptible espe-
cially to damage as a result of stress [35]. Women have a
higher incidence of some stress-related disorders, such as
depression, while men are generally at a greater risk for
cardiovascular diseases, such as myocardial infarction and
hypertension, than age-matched, premenopausal women
[36]. The higher incidence and severity of depression are
associated with the presence or absence of ovarian hor-
mones [37]. The present study showed hyperactivity of the
pro-inflammatory cytokine after stress. Pro-inflammatory
cytokine’s overproduction could be integrated in the in-
flammatory response system, which is activated during de-
pression, and this is consistent with the shift of the pro-/
anti-inflammatory cytokine mechanism. Buchanan et al.
reported that psychological stress increases the brain levels
of inflammatory cytokines such as interleukin-1β (IL-1β),
IL-6 and tumor necrosis factor α (TNF-α) [38]. Zili et al.
detected depression like behavior in a rat animal model
which was induced inflammation in the spleen and brain
by chronic mild stress (CMS) [39]. In the present study,
we observed that the expression of IL-1β immunoreactive
cells was up-regulated in paraventricular nucleus (PVN),
motor trigeminal nucleus (MTN), hippocampus after re-
peated immobilization stress. The results from depression-
like animal model were consistent with previous reports,
which indicated that life events and depressive symptoms
are associated with the rise of central cytokine such as
IL-1β in human MDD patents [40-47] and stress-treated
animals [48-50]. However, the administration of soyo-san
significantly reduced the expression of IL-1β. Menthae
herbam, a component of soyo-san modified prescription
on plasma metabolomics of rats with chronic immobi-
lization stress [51]. Angelicae gigantis radix, a component
of soyo-san, exhibited an anti-inflammatory effect in vitro,
in vivo and inhibits the stress-induced pathophysiological
changes in the central nervous system [52]. Also, paeoni-
florin has neuroprotective effect and inhibition of neuroin-
flammation [53].
Conclusion
In conclusion, soyo-san decreased the immobility time in
FST. Soyo-san also inhibited repeated stress induced IL-1β
production in hippocampus and PVN. These results have
shown that IL-1β, a pro-inflammatory cytokine, is an im-
portant molecule in the modulation of depressive-like be-
havior. This finding calls for a reappraisal of the “cytokine
hypothesis of depression”. Further studies are encouraged
to analyze the therapeutic effect of different levels of estro-
genic compounds, which lack feminine proprieties, on dif-
ferent setting of immune diseases.Competing interests
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